Literature DB >> 8411229

The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence?

T Frebourg1, S H Friend.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8411229     DOI： 10.1093/jnci/85.19.1554

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer.

Authors:  Ming Dong; Gang Ma; Wei Tu; Ke-Jian Guo; Yu-Lin Tian; Yu-Ting Dong
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Telomere dysfunction alters the chemotherapeutic profile of transformed cells.

Authors:  K H Lee; K L Rudolph; Y J Ju; R A Greenberg; L Cannizzaro; L Chin; S R Weiler; R A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.

Authors:  Anita K Bakrania; Bhavesh C Variya; Snehal S Patel
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

4.  p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.

Authors:  K Nylander; P Nilsson; C Mehle; G Roos
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

5.  Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.

Authors:  W J Wu; Y Kakehi; T Habuchi; H Kinoshita; O Ogawa; T Terachi; C H Huang; C P Chiang; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1995-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.